Last Price$203.11.2%
Market Cap$82.8B
8.1%
Peers median - 7.4%
18.7%
Peers median - 6.9%
66.3%
Peers median - 55.4%
27.1%
Peers median - 6.2%
Competing with CTAS
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$82.8B | 7.6 | $64.3 68.3% overvalued | 30.0% | $9,940.5M | $1,855.0M | 8.1% | 18.7% | 48.8% | 27.1% | 66.3% | |
$77.8B | 6.4 | $106.8 39.9% overvalued | 14.6% | $7,249.2M | $1,849.3M | 5.9% | 25.5% | 32.8% | 18.2% | 25.4% | |
$25.3B | 7.3 | $160.1 58.9% undervalued | (21.2%) | $10.1B | $2,857.8M | 4.7% | 28.3% | 72.2% | 5.6% | 70.6% | |
$18.7B | 7.7 | $80.8 20.3% overvalued | 35.1% | $4,279.2M | $1,001.4M | 15.4% | 23.4% | 56.3% | 5.9% | 73.4% | |
$11.6B | 6.6 | $63.8 178.0% undervalued | (28.5%) | £10.2B | £988.6M | 68.9% | 9.7% | 14.0% | 13.9% | 116.6% | |
$9,517.2M | 5.2 | $42.7 18.7% undervalued | 14.5% | $17.5B | $484.6M | (6.0%) | 2.8% | 7.1% | 6.4% | 40.2% | |
$4,251.8M | 5.7 | $128.9 81.1% undervalued | (16.0%) | $5,381.8M | $280.7M | 8.0% | 5.2% | 22.9% | 11.2% | 5.4% | |
$3,894.3M | 5.8 | $155.8 25.6% overvalued | 25.0% | $2,438.7M | $186.4M | 6.7% | 7.6% | 30.8% | 6.7% | 3.2% | |
$3,805.0M | 5.2 | $65.6 9.7% overvalued | (4.6%) | $1,813.5M | $110.8M | 14.0% | 6.1% | 10.1% | 2.5% | 103.0% | |
$3,453.2M | 5.3 | $139.8 155.8% undervalued | 28.5% | $8,359.3M | $167.2M | 3.2% | 2.0% | 34.8% | 3.7% | 81.5% | |
$2,171.4M | 5.2 | $1,369.0 10,162.2% undervalued | (17.0%) | $307.7B | $16.3M | 40,184.5% | 0.0% | 99.9% | (4.1%) | 2.2% |
Compare CTAS Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
Cintas CorporationCTAS
8.6x
8.9%
16.7%
16.4%
Median Peer Set
1.4x
6.4%
30.3%
5.9%
ABM Industries IncorporatedABM
0.6x
3.2%
(66.1%)
1.0%
AramarkARMK
0.6x
(7.7%)
(61.4%)
1.5%
CBIZ, Inc.CBZ
3.1x
14.0%
(67.8%)
2.3%
First Advantage CorporationFA
(0.4x)
(5.7%)
(39.5%)
4.9%
Global Payments Inc.GPN
3.9x
4.7%
63.5%
15.5%
Maximus, Inc.MMS
0.8x
8.2%
89.8%
5.8%
RB Global, Inc.RBA
5.2x
16.4%
114.3%
9.6%
Rentokil Initial plcRTO
1.2x
45.5%
25.6%
7.1%
Thomson Reuters CorporationTRI
10.9x
2.5%
49.0%
39.7%
UniFirst CorporationUNF
1.6x
8.7%
35.0%
6.0%
Compare CTAS Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Cintas Corporation (CTAS) revenue growth compare to peers and the industry?
Cintas Corporation (CTAS) revenue growth is 8.1%, compared to the peers' median of 7.4%.
2. How does Cintas Corporation (CTAS) Free Cash Flow (FCF) margin compare to peers and the industry?
Cintas Corporation (CTAS) FCF margin is 18.7%, compared to the peers' median of 6.9%.
3. How does Cintas Corporation (CTAS) Total Debt to Equity ratio compare to peers and the industry?
Cintas Corporation (CTAS) Total Debt to Equity ratio is 66.3%, compared to the peers' median of 55.4%.
4. How does Cintas Corporation (CTAS) ROIC (Return on Invested Capital) compare to peers and the industry?
Cintas Corporation (CTAS) ROIC is 27.1%, compared to the peers' median of 6.2%.